An interdisciplinary graduate training program that is closely integrated with the training programs in Neurosciences and Pharmacology. Multidisciplinary research opportunities utilize a variety of techniques from the molecular level to integrated systems and behavioral neuroscience. Faculty research focuses on the study of the effects of abused substances on cognition, receptors and signal transduction pathways, neuroimmune responses and development.
Project Director: Barbara M. Bayer, Ph.D.
University of California, Irvine
This program is designed to train pre-doctoral students in the fundamentals of pharmacology and neuroscience with a special emphasis on substance abuse research. The goal of the program is to expose trainees to substance abuse research and prepare them for independent research careers in neuroscience and pharmacology in basic science departments, medical schools, and non-academic research laboratories. The program combines training in molecular and cellular pharmacology with training in chemical neuroanatomy and behavioral neurosciences. The 20 primary faculty have appointments across five different departments. All mentors are experienced trainers with active research laboratories. The program supports six predoctoral traineeships.
Project Director: Daniele Piomelli, Ph.D.
University of Maryland
Pre-doctoral training program at the intersection of basic process research and clinical intervention for substance use. The program offers a wide range of interdisciplinary research and applied experiences at the University Of Maryland, College Park as well as with affiliated faculty at institutions in the greater Washington DC area (e.g., NIH, University of Maryland Medical School, Johns Hopkins University). In the context of a translational research project, trainees will receive joint supervision from one mentor affiliated with the cross-disciplinary Neuroscience and Cognitive Sciences (NACS) Program and the other mentor affiliated with the Center for Addictions, Personality, and Emotion Research (CAPER). Professional development will be a core feature of the program, including participation in an interactive speaker series, training in ethical conduct across both research and applied domains, access to research and clinical opportunities with underserved populations, and development of grant writing skills.
Project Directors: Carl W. Lejuez, Ph.D. (Clinical Core Director) firstname.lastname@example.org and Cynthia Moss, Ph.D. (Basic Process Core Director) email@example.com
University of Michigan
Interdisciplinary training program with research opportunities ranging from the level of molecular biology, to integrative and systems neuroscience to behavioral pharmacology. Faculty study a wide range of abused substances and neural systems related to their actions, including opioids, psychomotor stimulants, PCP, nicotine and sedative-hypnotics.
Project Director: Terry Robinson, Ph.D.
University of North Carolina
The Predoctoral training program at the University of North Carolina/Chapel Hill provides training in areas related to drug and alcohol abuse, including an emphasis in the following research areas: neurobiology, neuropharmacology, neuroimmunology, behavioral pharmacology and genetic/behavioral correlates of drug dependence. Research ranges from animal models to human studies and training covers both neurobiological and behavioral approaches. Prospective applicants can enter the program either through the Behavioral Neuroscience program within the Department of Psychology or through the Biological, Biomedical Sciences Program within the School of Medicine.
Program Directors: Linda Dykstra, Ph.D. firstname.lastname@example.org and Regina Carelli, Ph.D. email@example.com
University of Texas at Austin
This broad-based neuroscience predoctoral training program offers the opportunity for conducting cross-disciplinary research in collaborating laboratories. Faculty research interests range from the molecular, through the biochemical, physiological, and electrophysiological, to the behavioral and computational. Trainees will choose laboratories in which they will conduct research rotations and present seminars, take a prescribed set of core neuroscience courses, as well as choose from a wide variety of elective courses.
Project Director: R. Adron Harris, Ph.D.
Brown University, Center for Alcohol and Addiction Studies
The Center provides postdoctoral training that prepares fellows to conduct high quality clinical and pre-clinical substance abuse research. Key research programs ongoing at the Center include laboratory studies of tobacco and marijuana use; behavioral and pharmacologic intervention studies with smokers and substance abusers; effects of prenatal exposure to substances; and studies of intervention mechanisms (using a range of methods including electronic diaries, cue reactivity, behavioral economics, genetic markers, and fMRI). Fellows will be trained in conjunction with an existing NIAAA postdoctoral research program; in this integrated training program, a total of 14 fellows participate in a structured didactic seminar series, supervised research experience, and an intensive mentored grantwriting process. The Center's primary research focus is the discovery of more effective treatments and early interventions for alcohol and drug abuse. More information can be found at: http://www.caas.brown.edu/Content/training/.
Program Director: Damaris J. Rohsenow, Ph.D.
Training Director: Suzanne M. Colby, Ph.D.
Training Coordinator: Jayne Hawthorne
This is a post-doctoral training program focusing on the neural mechanisms underlying drug dependence. Studies will range from genetic analysis, synaptic plasticity, circuitry, second messenger systems, and characterization of the actions of receptors, transporters, and ion conductances, and explore the pathways of receptor and transporter regulation, neuritic pruning, modes of neuronal and glial cell death, and to establish pathways that may provide for regeneration. The ultimate goal of this program is to train the next generation of scientists to examine the effects of drug abuse.
Project Director: David Sulzer, Ph.D.
Post-doctoral training program for physicians and psychologists interested in pursing research careers in substance abuse. The primary goal is to provide future research and academic psychiatrists and other clinicians with the research skills and clinical expertise to play substantive roles in advancing knowledge about the etiology and treatment of substance use disorders. Research fields include basic neuroscience, genetics, epidemiology, behavioral pharmacology, epidemiology, psychopharmacology, clinical trials and treatment research.
Project Director: Frances Levin, M.D.
Johns Hopkins University
The Behavioral Pharmacology Research Unit (BPRU) offers diverse postdoctoral training in the human behavioral pharmacology of substance abuse and its treatment, with an emphasis on clinical trials. Areas of supervised research and publication training experience include: clinical trials of pharmacological and behavioral treatments, and their integration; incentive-based contingency management interventions; human laboratory studies of drug effects on behavior and cognition, drug self-administration, abuse liability assessment, and medications development. Drug categories under study include: opioids, cocaine/stimulants, sedative/anxiolytics, marijuana, psychedelics, alcohol, tobacco/nicotine, and caffeine.
Project Website: http://www.bpru.org
Program Director: George Bigelow, Ph.D.
McLean Hospital, Harvard Medical School Alcohol and Drug Abuse Research Center
Multidisciplinary postdoctoral training in clinical, preclinical, basic and treatment-related research on drug abuse is provided by faculty at the Alcohol and Drug Abuse Research Center. Trainees may participate in studies of behavioral pharmacology, neuroendocrinology, neurobiology, evaluation of novel analgesics, and brain imaging (MRI, MRS, fMRS). This research program also offers training in medicinal chemistry to develop novel medications, and in clinical and preclinical evaluations of the safety and effectiveness of new medications for drug abuse treatment. This Center focuses on drug abuse problems in women and gender comparisons, including the interactions between abused substances and neuroendocrine hormones.
Project Director: Nancy K. Mello, Ph.D.
McLean Hospital, Harvard Medical School, NeuroImaging Center
Post-doctoral training in the field of brain imaging and drug abuse is offered as an integrated, multidisciplinary program jointly supported by the McLean Hospital/Harvard Medical School and Boston University School of Medicine. The primary goal is to provide trainees with skills in brain imaging technology (MRI, MRS, fMRI, EEG) and advanced psychopharmacology to be used in basic science and applied research projects that include: acute intoxicating effects of drugs, cue-induced craving, cognitive effects, withdrawal, sleep disturbances, medication compliance, treatment, medication development as well as translational research between animals and humans. Training includes both formal course work and laboratory rotations via one of four tracks: 1) MR Technology and Instrumentation Track; 2) Basic Clinical Research Track; 3) Clinical Treatment Track; and 4) Translational Research Track.
Project Director: Scott E. Lukas, Ph.D.
Send CV and statement of research interests to: Ronna J. Shostak, BPRL, McLean Hospital, 115 Mill St., Belmont, MA 02478, or email to firstname.lastname@example.org.
Mount Sinai School of Medicine
This is an interdisciplinary program that seeks to train researchers in the basic understanding and treatment of drug addiction. Our training faculty includes scientists and physicians engaged in both basic science and translational research. The research available to trainees in this program encompasses a wide variety of drugs of abuse (opioids, cannabinoids, cocaine, hallucinogens) as well as a full spectrum of research techniques including emerging techniques in genomics, proteomics, optogenetics and imaging, as well as approaches rooted in computational biology, structural biology, behavioral science, cell biology, molecular neuroanatomy, electrophysiology, molecular biology, functional magnetic resonance imaging and clinical research. Many of the faculty members have ongoing collaborations with each other, facilitating interdisciplinary work by trainees.
Project Website: http://www.mssm.edu/departments-and-institutes/pharmacology-and-systems-therapeutics/programs-and-training/postdoctoral-nida-training-in-pharmacology-of-drugs-of-abuse
Program Director: Lakshmi A. Devi, Ph.D.
New York University School of Medicine
Post-doctoral training program emphasizing basic and translational research. Faculty members have active research programs focusing on brain reward mechanisms, molecular biology of opioid receptors, signal transduction in tolerance and dependence, dopamine as an extrasynaptic neurotransmitter, structure, function, and regulation of monoamine transporters, preclinical development of medications against cocaine dependence, noradrenergic mechanisms of stress and psychostimulant effects, and CNS correlates of drug craving in humans.
NYU Addiction Center of Excellence Website: http://coe.addiction.med.nyu.edu/education/programs-and-seminars
Project Director: Kenneth D. Carr, Ph.D.
University of California, San Francisco
Postdoctoral program in drug abuse treatment and services research. Trainees work with a preceptor to design and implement studies on treatment of drug dependence, including nicotine dependence. Trainees also select a specific area of focus for independent research. Current research interests include trials of efficacy and effectiveness of psychosocial and pharmacologic treatment of drug abuse, including nicotine dependence; adoption of evidence-based practices in addiction treatment programs; instrument development in drug abuse; diagnostic techniques and research on treatment tailored for HIV positive drug abusers and drug abusers with psychiatric and medical disorders; research on provision of services to drug abusing populations; innovative methodology including internet based studies; and treatment of complex patients in innovative settings.
Program Director: James L. Sorensen, Ph.D.
University of Michigan
This program offers post-doctoral training in the area of neurobiology and pharmacology of drugs of abuse, especially opioids and stimulants. The emphasis is on promoting scientific growth and acquiring conceptual and experimental tools key to understanding a) the basic biology of neurotransmitters and their receptors and the mechanisms of action of opiate drugs; and b) the molecular, cellular, interneuronal and behavioral processes critical to drug seeking, drug dependence and drug tolerance. This endeavor is carried out in an interdisciplinary context, with research ranging from gene regulation to primate behavior.
Project Website: http://sitemaker.umich.edu/bda/home
Program Director: John Traynor, Ph.D.
Vanderbilt University Medical Center
The purpose of this Joint Program of Vanderbilt University Medical Center and Meharry Medical College is to appropriately prepare addiction psychiatrists embarking on combined clinical and research careers to engage in multidisciplinary research across the bench to bedside continuum. During this 2-year research training program, trainees will conduct an original interdisciplinary research project involving preceptors from at least two out of four conceptual frameworks (psychiatry, neuroimaging, molecular medicine, and biomedical informatics). They will also complete the required didactics for the Masters of Science in Clinical Investigation. Qualified applicants are either board eligible in Addiction Psychiatry or may complete clinical requirements prior to their research through an accelerated track at the Vanderbilt Department of Psychiatry.
Project Director: Peter R. Martin, M.D., Ph.D.
Multidisciplinary post-doctoral training program in drug abuse research with preceptors from the Departments of Psychiatry, and the Division of Biostatistics and Infectious Diseases. Research facilities include a renovated center for genetic and epidemiologic studies with access to inpatients and outpatients of Barnes Jewish, Bliss and Childrens Hospitals.
Project Director: Theodore J. Cicero, Ph.D.
The central theme of the research in this post-doctoral program is the development and evaluation of innovative pharmacologic and behavioral treatments for substance abusers. Training can range in areas from molecular neurobiology and genetics to pharmacology and behavioral treatments, psychiatric epidemiology and health services research of drug abuse. This is a rich training environment, faculty with broad interests, many are world-renowned in their field.
Project Director: Ismene Petrakis, M.D.
Yale University School of Medicine
This Postdoctoral Training Program in Substance Abuse Prevention Research is located within the Division of Prevention and Community Research and The Consultation Center, Department of Psychiatry, Yale University School of Medicine. A combination of didactic, mentored, and independent research experiences over a two-year period is aimed at preparing future prevention scientists for careers as independent investigators with expertise in the development, implementation, and rigorous evaluation of science-based substance abuse prevention research. The program emphasizes three fundamental areas of learning:  conceptualization, design, and implementation of research within an ecological framework;  process of knowledge development and application in prevention science; and  research methodologies. Training includes state-of-the-art quantitative research methods and data analytic approaches, especially for the analysis of longitudinal research designs. Extensive training is also provided on the ethical conduct of research.
Project Website: http://www.theconsultationcenter.org/index.php?/post-doctoral.html
Program Director: David L. Snow, Ph.D
Co-Program Director: Jacob K. Tebes, Ph.D.
Yale University School of Medicine
Yale University has established a T32 program for interdisciplinary training in sciences related to neuroimaging. Neuroimaging technologies and applications today require a broad range of knowledge to establish and employ. The goal of this training program is to use its four postdoctoral training slots to cross-train basic scientists and physicians in technical, mathematical, biological, and administrative areas that are needed for modern neuroimaging studies.
Project Director: Graeme Mason, Ph.D.
Albany Medical College
This training program in neuropharmacology and neuroscience provides a multifaceted approach to understanding mechanisms of abused drugs and to developing new agents for treating addiction through an integrated program of didactic work and in-depth research experiences.
Project Director: Stanley Glick, M.D., Ph.D.
Brown University, The Miriam Hospital
This post-doctoral training program focuses on clinical research training in the areas of prevention, diagnosis, and treatment of HIV, Hepatitis B and C, and STDs among substance users. The goal is to train MDs and PhDs in prevention intervention research and interventions to improve treatment and access to therapy for HIV, Hepatitis, TB, and STDs among "hard to reach" populations.
Project Director: Timothy P. Flanigan, M.D.
Administrator: Jennifer Hyde
The Substance Abuse Epidemiology Training Program at Columbia University trains individuals from different disciplines for careers and leadership in substance abuse epidemiology. We train pre- and post-doctoral fellows to use epidemiologic methods to understand the onset, course, and consequences of substance abuse, and to transform such understanding into actions that mitigate the toll substance abuse takes on individuals and on society. We emphasize a multi-level, cells-to-society approach and our training goals include gaining knowledge about substance abuse epidemiology and related areas, building a set of methodological skills, presenting findings in professional settings, and becoming trained in the responsible conduct of research.
Program Director: Deborah Hasin, Ph.D.
Cornell University Weill Medical College
The Pharmacology-Neuroscience Drug Abuse Training Program will provide the opportunity for young investigators to participate in basic and clinical research in drug abuse. Training Faculty interests include the phenotypic consequences for pain states, opioid tolerance, reward, anxiety or gaseous anesthetic action of the mutation or deletion of opioid, glutamatergic, GABA or serotonergic receptors, the role soluble and transmembrane adenylyl cyclases in opioid signal transduction, in vivo receptor and drug imaging techniques, anatomical and ultrastructure characterization of the dopaminergic, glutamatergic and opioid peptides systems as they relate to the effects of drugs of abuse, the biological basis of opioid, cocaine and alcohol tolerance and dependency, maternal-fetal pharmacodynamics of drugs of abuse, drug abuse prevention research and the clinical pharmacokinetics and pharmacodynamics of opioid and nonopioid analgesics. Predoctoral trainees will have a choice of a major concentration in either Pharmacology or Neuroscience. In addition to lectures and seminars devoted to topics in drug abuse, both the 5 pre and the 5 postdoctoral trainees will attend a biweekly Pain Conference at MSKCC where patient presentations are followed by a discussion with a multidisciplinary Pain Research Team of pain management, drug abuse and related issues. The program provides training in study design, biostatistics and the ethics of scientific research.
Project Director: Charles Inturrisi, Ph.D.
This training program in The Neurobiology of Drug Abuse focuses on the mechanisms of drug use/abuse /dependence/treatment and offers interdisciplinary training. The 20 faculty offer research in clinical problems, brain imaging, behavioral models, neuroanatomy, drug receptors and signal transduction, medications development, and molecular biology and genetics.
Program Website: http://research.yerkes.emory.edu/neuroscience/training/drugabuse/index.html
Program Director: Michael J. Kuhar, Ph.D.
Johns Hopkins Bloomberg School of Public Health
The primary goal of this new training program is to increase the number and quality of quantitatively adept scientists who, after training, will conduct population field studies and other epidemiologic research on drug dependence and on related hazards associated with illicit drug use.
Project Director: Debra Furr-Holden, Ph.D.
Public Health Solutions
This training program is designed to prepare social scientists for careers in research on drug abuse and HIV/AIDS. Training activities at National Development and Research Institutes (NDRI) emphasize: advanced courses in drug abuse theory and research methods and in substantive issues related to AIDS, crime, and other drug related topics. Fellows attend appropriate doctoral level courses at Columbia University, School of Public Health or other New York area universities.
Program Director: Gregory Falkin, Ph.D.
Medical University of South Carolina
Pre-doctoral and post-doctoral training for individuals who are interested in a multidisciplinary basic science and/or clinical approach to drug abuse issues. Our expertise is in translating research on the mechanisms of drug seeking behavior and its molecular/cellular substrates into pharmacotherapies for drug addiction. This site is the home of the Neurobiology of Addiction Research Center (Peter Kalivas-PI); the Translational Research on Addiction Center (Ronald See-PI) http://academicdepartments.musc.edu/neurosciences/research/index.html; and a Specialized Center of Research in Addiction (Kathleen Brady-PI) http://www.musc.edu/psychiatry/research/cns/SCOR/About%20SCOR/aboutscor.htm.
Program Director: Jacqueline F. McGinty, Ph.D.
Michigan State University College of Human Medicine
This is an epidemiological research training program for graduate students, post-doctoral fellows, and summer research apprentices. The scientific focus is on drug dependence epidemiology and intervention research, with a multi-level population and ecological perspective. We pose research questions under five main rubrics of substantive epidemiology, as well as methodological research questions, and we seek increasingly definitive answers to questions of public health significance. The program provides talented investigators with opportunities to join ongoing NIDA-funded research projects and to design their own experiments, based on theories and research approaches of epidemiology and biostatistics, as well as the life-span developmental sciences, econometrics, and systems analysis.
Program Website: http://http://www.epi.msu.edu/nida/
Program Director: James C. Anthony, Ph.D.
Staff Contact: Jayne Goeddeke
The Center for Drug Discovery training program provides interdisciplinary training in the area of drug discovery and development. Our primary objective is to familiarize pre- and post-doctoral trainees with the chemical, physiological, pharmacological, and clinical aspects of pharmacotherapeutics for treating substance abuse, with particular focus on modulators of the endocannabinoid signaling system. This training program is broadened by the participation of premier scientists and laboratories from the pharmaceutical and biotechnology industries, as well as from clinical and translational research centers. Pre-doctoral students will earn a Ph.D. either in Pharmaceutical Sciences or in Chemistry and Chemical Biology; post-doctoral fellows will be trained in areas that include medicinal chemistry, structural and molecular biology, biochemical pharmacology, behavioral science, proteomics, metabolomics, and in vivo imaging, and may choose mentored academic projects at any of six program sites.
Northeastern University's Website: www.northeastern.edu
Project Director: Alexandros Makriyannis, Ph.D.
Oregon Health & Science University
This program will train specialists to conduct preclinical research ranging from the molecular to the behavioral level on the biological mechanisms underlying the development, maintenance, and elimination of drug-seeking behavior. Thirty-one faculty will serve as preceptors for trainees at the cellular/molecular level, using molecular biological, electrophysiological, and fluorescence and electron microscopic techniques; at the level of physiological, biochemical, and pharmacological systems, using receptor binding, autoradiography, in vivo microdialysis and voltammetry, in vitro perfusion, and electrophysiological techniques; in pharmacogenetics and behavioral pharmacology, using behavioral testing, intravenous drug self-administration, quantitative genetics, and genetic mapping techniques; and at the cognitive/human/clinical level, using behavioral tests, EEG, fMRI and diffusion tensor imaging, and PET scanning.
Project Director: Kim Neve, Ph.D.
Pennsylvania State University
This training program focuses on the interface of prevention research and methodology. The goal is train researchers in the development and application of cutting-edge research methods in the design and evaluation of substance abuse" and comorbid prevention programs for children, youth, families, and communities. The training program will develop researchers who: (1) are knowledgeable about the central principles and models of prevention science, (2) can utilize sophisticated modeling techniques for longitudinal data, and (3) have the capacity to translate these skills into development and refinement of strategies to improve the lives of young people. The program combines the strengths of the Prevention Research Center and The Methodology Centers to provides a high-quality, interdisciplinary training environment. More information can be found at http://methodology.psu.edu/pamt/.
Project Director: Mark Greenberg, Ph.D. email@example.com
Training Director: Ed Smith, Ph.D.
Temple University School of Medicine
This program provides interdisciplinary training in several areas of drug abuse research including behavioral, cellular, and molecular pharmacology, neuroscience, and immunology. Our current research emphasis is on investigating the effects of opioids, cocaine, cannabinoids, and nicotine on behavior and on the brain and immune system. Training of predoctoral and postdoctoral fellows from the Departments of Pharmacology, Microbiology and Immunology, Psychology, Biochemistry, and Physiology is provided, with experienced drug abuse researchers in each department to serve as mentors. This program provides the trainees with the opportunity to learn a variety of research skills in a collaborative and supportive atmosphere, and helps prepare them for independent careers in academia, industry, or government. Temple University has a large, active Center for Substance Abuse Research which supports research efforts on drugs of abuse and addiction. Detailed research program descriptions can be found on our web sites, Center for Substance Abuse Research and www.temple.edu/medicine.
Program Director: Ellen Unterwald, Ph.D.
University of Arkansas for Medical Sciences
This unique training program is in an emerging area—translational research in addiction. Trainee research opportunities will include, among many others, laboratory studies of antibody-based therapy for methamphetamine abuse, studies of the behavioral economics of addiction, novel medications to treat cocaine and opiate dependence, behavioral treatments of marijuana dependence, behavioral and neural mechanisms of change, treatment service dissemination, and cost effectiveness of reducing drug treatment barriers. The project will train addiction scientists to participate in translational science that directly assesses the clinical relevance of basic research; conduct scientific analyses of basic processes underlying drug abuse; help develop and assess behavioral and pharmacological treatments of addiction; determine approaches to integrate these findings into clinical practice; and identify policies that support integration. Scientists trained in translational research will be at the crossroads of basic and clinical research, where they can provide a crucial pathway between these two domains.
Program Director: Warren Bickel, Ph.D.
University of California, Los Angeles
The UCLA Drug Abuse Research Training Center has provided training in drug abuse research to pre and post-doctoral fellows since its inception in 1991. This program will continue to include trainees at all levels of experience, including MDs. The objectives of the DARTC program are to provide intensive, comprehensive, integrated, interdisciplinary research training to an ethnically and experientially diverse group of trainees. In addition, trainees have access to large populations using every drug of abuse, from all racial and cultural backgrounds and from varied socioeconomic levels, set amid urban, suburban, and rural communities. The curriculum covers virtually every area of drug abuse research, including epidemiology, etiology, pharmacology, neurobiology, HIV/AIDS, the natural history of use/dependence, and the development and evaluation of pharmacological and behavioral interventions.
Project Director: Richard A. Rawson, Ph.D.
University of California, San Diego
The University of California San Diego and San Diego State University co-sponsor a T32 program focused on substance use, HIV and related infections that aims to train the next generation of behavioral researchers in public health disciplines (e.g. epidemiology, psychology, global health, public health law, health behavior). The program currently has 3 predoctoral and 3 postdoctoral training slots. A unique feature of this program is the opportunity to engage in hands-on training in international drug abuse research, as several of the faculty have active research programs in the Mexico-US border region.
Program Website: http://gph.ucsd.edu
Program Director: Steffanie Strathdee, Ph.D.
University of Chicago
This training program emphasizes an interdisciplinary approach aimed at characterizing the multiple actions of different drugs and deciphering the behavioral and neurobiological factors that contribute to their abuse. Research programs span the neuropsychopharmacology, biochemistry, electrophysiology, genetics, and molecular biology of drug effects through to the study of behavioral and subjective effects of drugs in humans.
Program Director: Paul Vezina, Ph.D.
University of Colorado - Boulder
The pre- and postdoctoral programs at the Institute for Behavioral Genetics (IBG) provide training in the development and use of genetic strategies to study behavior, in general, and substance abuse in particular. Predoctoral students receive didactic training in molecular genetics, quantitative genetics, and behavioral genetics. All IBG predoctoral trainees are also graduate students in regular academic departments of the University of Colorado (e.g. Psychology and Neuroscience, Integrated Physiology, Molecular Cellular and Developmental Biology) and must, as a result, take the coursework required by the relevant academic department to complete the Ph.D. Both pre- and postdoctoral trainees will participate actively in drug abuse-related projects directed by IBG's faculty. This research ranges from animal model to human studies.
Program Director: John K. Hewitt, Ph.D.
University of lllinois - Chicago
Pre- and Post-doctoral training focuses on the etiology and prevention of adolescent substance abuse, violence, unsafe sexual behaviors and AIDS. We emphasize longitudinal etiology research and randomized trials of prevention programs. The program is located in the Institute for Health Research and Policy, a cluster of 5 interdisciplinary research centers administered by the School of Public Health. This program allows fellows to work closely with faculty from various disciplines on ongoing etiology and prevention research projects and develop their own research programs.
Project Director: Robin Mermelstein, Ph.D.
University of Kentucky
This is an interdisciplinary program involving 14 faculty from a variety of departments including Anatomy and Neurobiology, Behavioral Science, Molecular and Cellular Biochemistry, Pharmacy, and Psychology whose objective is to prepare predoctoral and postdoctoral trainees for a career in drug abuse research. There is a rich tradition of drug abuse research at the University of Kentucky that currently includes a Center on Drug and Alcohol Research and a Center for Drug Abuse Research Translation. This program provides broad-based training in modern concepts of drug abuse research with an emphasis on studies of receptors involved in drugs of abuse, the development of ligands which interact with these receptors, enzymes that regulate opioid peptide action, and neuroAIDS. The focus of the training program is on the use of a spectrum of state-of-the-art methodological approaches such as structural biology, proteomics, molecular modeling, and microarray technology in conjunction with molecular biology, pharmacology and basic neuroscience to explore the mechanisms that are the foundation of drug abuse research.
Program Director: Linda P. Dwoskin, Ph.D.
University of Kentucky, College of Medicine
Predoctoral and postdoctoral training program in health and drug abuse research that spans preclinical and clinical methodologies to community level interventions. Those selected for the program will be trained to solve research problems in interdisciplinary teams. The training faculty serve as models of multidisciplinary collaboration in the disciplines of psychology, pharmacology, sociology, neuroanatomy, nursing, psychiatry, public health, and communications. Their research is carried out in the laboratories, clinic research wards, community treatment centers, criminal justice settings, and residential research facilities.
Program Director: Craig R. Rush, Ph.D.
University of Michigan
This training program puts into practice the cutting-edge concepts of interdisciplinarity and translational research at the intersection of behavioral, epidemiological, and neurobiological investigation of substance abuse. Trainees are exposed to a critical analysis of extant research on substance abuse through pro-seminars, interdisciplinary speakers and discussion groups. Trainees are expected to write for and present to multidisciplinary audiences as well as develop research competencies in their respective disciplines. Trainees will work with two faculty mentors, one mentor from the trainee's discipline and the other mentor from a complementary discipline.
Program Director: Margaret Gnegy, Ph.D.
University of Minnesota (PharmacoNeuroImmunology)
The PharmacoNeuroImmunology (PNI) program http://www.ahc.umn.edu/pni/ is an interdisciplinary training program that focuses on the intersections of drugs of abuse with the nervous and immune systems, and integrates our understanding of these physiological interactions with their behavioral counterparts, including the role of the drugs of abuse as co-factors in HIV/AIDS. The faculty trainers have extensive experience as mentors and are committed to training predoctoral students and postdoctoral fellows in this interdisciplinary setting.
Program Director: Thomas Molitor, Ph.D.
Program Co-Director: Sabita Roy, Ph.D.
University of Minnesota
This is an interdisciplinary training program in the biology of drug abuse. Research training is available in laboratories offering a variety of experiences, e.g. receptor studies, signal transduction, transmitter neuropharmacology, animal and human behavioral pharmacology all approached from either a mechanistic or intervention strategy.
Project Director: Thomas Molitor, Ph.D.
University of Pennsylvania
This program provides clinical and research training for physicians and post-doctoral researchers who wish to become qualified in treatment research for IV substance abusing patients, particularly as it relates to the care of those infected with, or at high risk, for infection with HIV. Trainees will be fully trained in all of the current behavioral psychological and pharmacological techniques.
Project Director: Charles O'Brien, M.D.
University of Rochester
This program takes an interdisciplinary approach to the broad spectrum of the problems of drug abuse and the many directions of drug abuse research. The four divisions of the training program include: Behavioral Pharmacology, Biochemical Pharmacology, Clinical Pharmacology, and Molecular Pharmacology. Pre-doctoral students will be able to receive a Ph.D. degree from several interdisciplinary programs, including pharmacology, toxicology, psychology, and neuroscience.
Project Director: Jean Bidlack, Ph.D.
University of Texas Medical Branch at Galveston
This program provides both pre- and postdoctoral training in the behavioral and biochemical mechanisms of actions of drugs of abuse, especially psychomotor stimulants, opiates and phencyclidine. Anatomic, behavioral, biochemical, cellular and genetic approaches are used. Students, as well as the training faculty, come from graduate programs in pharmacology and toxicology, neuroscience, cell biology, biochemistry and molecular biology. Training is facilitated by resources made available through the Center for Addiction Research (CAR) headed by Dr. Kathryn Cunningham (see http://www.utmb.edu/addiction/).
Program Director: Kenneth M. Johnson, Ph.D.
The University of Texas Southwestern Medical Center at Dallas
Our program offers research training in diverse areas of neuroscience directly relevant to drug abuse and addiction. A distinguishing feature of the program is its multidisciplinary orientation. There is ongoing research at the level of molecular biology, genetics, cellular physiology, neuroanatomy, neuropharmacology, and behavioral neuroscience, and most trainees carry out research that spans several of these various disciplines. Trainees also benefit from the outstanding biomedical research community at UT Southwestern.
Program Director: Amelia J. Eisch, Ph.D.
University of Vermont
This training program focuses on the behavioral economics and behavioral pharmacology of addiction, with a special focus on vulnerable populations and health disparities. Trainees have opportunities to gain research experience with a wide range of NIH-supported behavioral, neurobiological, and pharmacological human laboratory and treatment outcome research, and to gain unique training in tobacco regulatory science. This training program is integrated with the University of Vermont’s Tobacco Center of Regulatory Science and the Vermont Center on Behavior and Health (http://www.uvm.edu/medicine/behaviorandhealth/), a trans-disciplinary center dedicated to researching the impact of substance use and other health risk behaviors on chronic disease and premature death.
Project Director: Stephen T. Higgins, Ph.D.
University of Washington
The unique strength of this faculty group is their expertise in the molecular pharmacology of signal transduction mechanisms likely to be affected by drugs of abuse. Previous research by this group includes 1) studies of the effects of opioids, phencyclidine, and cannabinoids on ion channel function, 2) the structure and biochemical properties of channels and enzymes known to be regulated by drugs of abuse, and 3) the effects of chronic exposure of opiates on the properties of specific neurons in the mammalian brain.
Project Director: Charles Chavkin, Ph.D.
University of Washington
This Nursing Research Training Program in Substance Abuse is interdisciplinary and offers two post-doctoral research fellowships for individuals holding a doctorate in Nursing; and two fellowships for individuals holding a doctorate in Psychology, Social Work, Psychiatry and/or other heath care disciplines. Additionally, there are two pre-doctoral traineeships for students enrolled in the University of Washington School of Nursing doctoral program. The training foci of this program are substance abuse epidemiological research and treatment research. The training opportunities, particularly in treatment research, are excellent. A NIDA Clinical Trials Network (CTN) is in progress at the University of Washington. There are ongoing clinical trials that combine psychosocial treatment with medication, intervention studies on substance abuse co-morbidities, and projects in the corrections/criminal justice/prison system. Numerous other training opportunities with other federally-funded mentor projects are also available.
Project Director: Elaine Adams Thompson Ph.D., RN
Virginia Commonwealth University
The principal objective of this training program is to prepare pre-doctoral and post-doctoral students for academic careers as independent scientists in the area of drug abuse research. Pre-doctoral students may enter the drug abuse training program after completing at least one year in the graduate program of the department. They will have had courses in biochemistry, physiology and general pharmacology and will have been exposed to research in at least four different laboratories by the time that they enter the drug abuse training program.
Project Director: William Dewey, Ph.D.
Washington University, George Warren Brown School of Social Work
The Social Work Training in Addictions Research (STAR) pre-doctoral and post-doctoral training program focuses on research on services and treatment of substance abusing and comorbid populations. Trainees benefit from our program's affiliation with several NIH supported centers at the Brown School of Social Work and across the University with emphasis on transdisciplinary research and the provision of social work and public health prevention and intervention services for drug, alcohol, and comorbid problems to underserved populations. The program prepares trainees for academic research placements in tenure track or post-doctoral fellowship positions.
Program Co-Director: Renee M. Cunningham-Williams, Ph.D., MPE, LCSW
Washington University School of Medicine
This program offers a broad range of research opportunities for individuals wishing to give primary emphasis in their research to drug abuse epidemiology, comorbidity, prevention, assessment or biostatistics. This program seeks to recruit and equip researchers from other backgrounds such as social work, infectious disease and public health, with the special skills that are needed to address challenging problems that are specific to drug abuse research.
Project Director: Linda Cottler, Ph.D.
- Funding Opportunities
- Clinical Research
- Post-Award Concerns
- General Information
- Grant & Contract Application Process
- Funding Priorities
- Research Training
- Extramural Research Training & Career Development
- What to know about the Predoctoral Process - Pre-application
- What to know about the Predoctoral Process - Application
- What to know about the Predoctoral Process - Grant Maintenance
- What to know about the Predoctoral Process - Transition
- What to know about the Postdoctoral Process - Pre-application
- What to know about the Postdoctoral Process - Application
- What to know about the Postdoctoral Process - Grant Maintenance
- What to know about the Postdoctoral Process - Transferring
- What to know about the Postdoctoral Process - Transition
- Research Training Committee
- Blueprint Research Training Sites - Imaging
- Blueprint Research Training Sites - Computational
- High School and Undergraduate Training
- Predoctoral or Medical Students
- Postdoctoral Researchers or Clinical Residents
- Early-Career Awards
- Mid-Career Awards
- Institutional Awards
- Loan Repayment Program (LRP)
- Research Training Sites
- Extramural Research Training & Career Development
Get this Publication
Search for Funding
Discusses the importance of quality mentorship in drug abuse research and offers suggestions for creating a successful mentor and mentee relationship.